The FLOW trial showed a 24% reduction in major kidney disease events in T2D with CKD over a median of 3.4 years
Patients were required to have at least one unsuccessful dietary weight-loss attempt and also completed a 12-week lifestyle intervention run-in phase
The adjustment can cause a temporary energy dip as the body finds a new balance
Askari M, Faryabi R, Mozaffari H, et al
In 2024, we also saw unprecedented willingness by large numbers of patients to pay out of pocket, even in European markets, as public coverage of AOMs is still limited, at best, and more often non-existent
Rated 5 out of 5 Anonymous (verified owner) Month three, on the 7.5mg dose now, and still having a great experience with Citizen Meds